{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T04:54:07Z","timestamp":1664859247105},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12664-022-01270-3","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T08:03:47Z","timestamp":1656576227000},"page":"405-414","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Uday C.","family":"Ghoshal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Blaachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmita","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"1","key":"1270_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12664-020-01135-7","volume":"40","author":"UC Ghoshal","year":"2021","unstructured":"Ghoshal UC, Singh R, Rai S. Prevalence and risk factors of gastroesophageal reflux disease in a rural Indian population. Indian J Gastroenterol. 2021;40:56\u201364.","journal-title":"Indian J Gastroenterol."},{"issue":"2","key":"1270_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12664-020-01104-0","volume":"40","author":"S Rai","year":"2021","unstructured":"Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: A meta-analysis and meta-regression study. Indian J Gastroenterol. 2021;40:209\u201319.","journal-title":"Indian J Gastroenterol."},{"key":"1270_CR3","doi-asserted-by":"crossref","unstructured":"Karyampudi A, Ghoshal UC, Singh R, Verma A, Misra A, Saraswat VA.\u00a0Esophageal acidification during nocturnal acid-breakthrough with Ilaprazole versus Omeprazole in gastroesophageal reflux disease. J Neurogastroenterol Motil. 2017;23:208\u201317.","DOI":"10.5056\/jnm16087"},{"issue":"6","key":"1270_CR4","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/00365520701864635","volume":"43","author":"UC Ghoshal","year":"2008","unstructured":"Ghoshal UC, Chourasia D, Tripathi S, Misra A, Singh K. \u00a0Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry. Scand J Gastroenterol. 2008;43:654\u201361.","journal-title":"Scand J Gastroenterol."},{"key":"1270_CR5","doi-asserted-by":"crossref","unstructured":"Naik RD, Evers L, Vaezi MF. Advances in the diagnosis and treatment of GERD: New tricks for an old disease. Curr Treat Options Gastroenterol. 2019;17:1\u201317.","DOI":"10.1007\/s11938-019-00213-w"},{"key":"1270_CR6","doi-asserted-by":"crossref","unstructured":"Scarpignato C, Hongo M, Wu JCY, et al. Pharmacologic treatment of GERD: Where we are now, and where are we going? Ann N Y Acad Sci. 2020;1482:193\u2013212.","DOI":"10.1111\/nyas.14473"},{"key":"1270_CR7","doi-asserted-by":"crossref","unstructured":"Bhatia SJ, Reddy DN, Ghoshal UC, et al. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2011;30:118\u201327.","DOI":"10.1007\/s12664-011-0112-x"},{"issue":"2","key":"1270_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12664-011-0095-7","volume":"30","author":"UC Ghoshal","year":"2011","unstructured":"Ghoshal UC, Chourasia D. Genetic factors in the pathogenesis of gastroesophageal reflux disease. Indian J Gastroenterol. 2011;30:55\u201362.","journal-title":"Indian J Gastroenterol."},{"key":"1270_CR9","doi-asserted-by":"crossref","unstructured":"Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. \u00a0BMC Med. 2016;14:179.","DOI":"10.1186\/s12916-016-0718-z"},{"issue":"9","key":"1270_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1046\/j.1365-2036.2001.01050.x","volume":"15","author":"S Xue","year":"2001","unstructured":"Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001;15:1351\u20136.","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"1270_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.12504","volume":"38","author":"DA Peura","year":"2013","unstructured":"Peura DA, Pilmer B, Hunt B, Mody R, Perez MC. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2013;38:1303\u201311.","journal-title":"Aliment Pharmacol Ther."},{"key":"1270_CR12","doi-asserted-by":"crossref","unstructured":"Goh KL, Choi MG, Hsu PI, et al. Pharmacological and safety profile of Dexlansoprazole: A new proton pump inhibitor - Implications for treatment of gastroesophageal reflux disease in the Asia Pacific Region. J Neurogastroenterol Motil. 2016;22:355\u201366.","DOI":"10.5056\/jnm15150"},{"key":"1270_CR13","doi-asserted-by":"crossref","unstructured":"Fass R, Johnson DA, Orr WC, et al. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol. 2011;106:421\u201331.","DOI":"10.1038\/ajg.2010.458"},{"key":"1270_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/CEG.S91602","volume":"9","author":"J Mermelstein","year":"2016","unstructured":"Mermelstein J, Mermelstein AC, Chait MM. Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole. Clin Exp Gastroenterol. 2016;9:163\u201372.","journal-title":"Clin Exp Gastroenterol."},{"issue":"3","key":"1270_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1572-0241.2003.07304.x","volume":"98","author":"TM Ours","year":"2003","unstructured":"Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol. 2003;98:545\u201350.","journal-title":"Am J Gastroenterol."},{"key":"1270_CR16","doi-asserted-by":"crossref","unstructured":"Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411\u201340.","DOI":"10.1007\/s12664-019-00979-y"},{"key":"1270_CR17","doi-asserted-by":"crossref","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u201320; quiz 43.","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"1270_CR18","doi-asserted-by":"crossref","unstructured":"Ghoshal UC, Singh R. Catheter-based 24-h pH-metry and impedance: Technique, interpretation, and clinical application. In: Evaluation of Gastrointestinal Motility and its Disorders: (Ed. Ghoshal UC) Springer, India. 2016:95-106..","DOI":"10.1007\/978-81-322-0822-8_9"},{"issue":"2","key":"1270_CR19","first-page":"157","volume":"4","author":"HF Hill","year":"1989","unstructured":"Hill HF, Chapman CR, Jackson TL, Sullivan KM. Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation. Bone Marrow Transplant. 1989;4:157\u201361.","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"1270_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000210107","volume":"27","author":"J Weigt","year":"2009","unstructured":"Weigt J, Kandulski A, Busch F, Malfertheiner P. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients. Dig Dis. 2009;27:68\u201373.","journal-title":"Dig Dis."},{"issue":"Suppl 1","key":"1270_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000200917","volume":"51","author":"NJ Bell","year":"1992","unstructured":"Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51 Suppl 1:59-67.","journal-title":"Digestion."},{"issue":"12","key":"1270_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1046\/j.1365-2036.1998.00426.x","volume":"12","author":"JG Hatlebakk","year":"1998","unstructured":"Hatlebakk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998;12:1235\u201340.","journal-title":"Aliment Pharmacol Ther."},{"key":"1270_CR23","unstructured":"Matveev VI. Method of measured administration of radioactive aerosols to dogs.\u00a0Gig Sanit. 1971;36:69-72."},{"issue":"6","key":"1270_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/MCG.0b013e31814a4e5c","volume":"42","author":"I Mainie","year":"2008","unstructured":"Mainie I, Tutuian R, Castell DO. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008;42:676\u20139.","journal-title":"J Clin Gastroenterol."},{"issue":"8","key":"1270_CR25","first-page":"1570","volume":"62","author":"E Hoshino","year":"2004","unstructured":"Hoshino E, Ishiyama A, Tsuchida T. PPI: new strategies for GERD. Nihon rinsho Jpn J Clin Med. 2004;62:1570\u20136.","journal-title":"Nihon rinsho Jpn J Clin Med."},{"key":"1270_CR26","doi-asserted-by":"crossref","unstructured":"Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: What may be the relationship? J Neurogastroenterol Motil. 2010;16:243\u201350.","DOI":"10.5056\/jnm.2010.16.3.243"},{"issue":"1","key":"1270_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12664-010-0078-0","volume":"30","author":"D Chourasia","year":"2011","unstructured":"Chourasia D, Misra A, Tripathi S, Krishnani N, Ghoshal UC. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry. Indian J Gastroenterol. 2011;30:12\u201321.","journal-title":"Indian J Gastroenterol."},{"key":"1270_CR28","unstructured":"Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90: 1401\u20136."},{"key":"1270_CR29","doi-asserted-by":"crossref","unstructured":"Schenk BE, Kuipers EJ, Nelis GF, et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut. 2000;46:615\u201321.","DOI":"10.1136\/gut.46.5.615"},{"key":"1270_CR30","doi-asserted-by":"crossref","unstructured":"Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol. 2005;19:15\u201335.","DOI":"10.1155\/2005\/836030"},{"key":"1270_CR31","doi-asserted-by":"crossref","unstructured":"Graham DY, Tansel A. Interchangeable use of proton pump inhibitors based on relative potency. Clin Gastroenterol Hepatol. 2018;16:800\u20138 e7.","DOI":"10.1016\/j.cgh.2017.09.033"},{"key":"1270_CR32","doi-asserted-by":"crossref","unstructured":"Shetkar SS, Ramakrishnan S, Seth S, et al. CYP 450 2C19 polymorphisms in Indian patients with coronary artery disease. Indian Heart J. 2014;66:16\u201324.","DOI":"10.1016\/j.ihj.2013.10.001"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-022-01270-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T01:13:19Z","timestamp":1664845999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-022-01270-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1007\/s12664-022-01270-3","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UCG, AB, SR, and AM\u00a0declare no conflict of\u00a0 interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed conforming to the Helsinki declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.The study was reviewed and approved by SGPGIMS Institutional Ethics Committee (IEC Code 2017-39-IP-96).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the paper\u2019s contents. In no way are the honorary editor in chief, editorial board members, the Indian Society of Gastroenterology, or the printer\/publishers responsible for this article\u2019s results\/findings and content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}